NCT06739174

Brief Summary

This 3-way crossover study aims to evaluate whether colostomy bags with an active chamber filter system reduce the incidence of filter-related complications, such as ballooning and pancaking, help neutralise odour, and minimise faecal leakage through the filter compared to colostomy bags with a protective filter

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 29, 2024

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

December 9, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 18, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

December 18, 2024

Status Verified

December 1, 2024

Enrollment Period

5 months

First QC Date

December 9, 2024

Last Update Submit

December 12, 2024

Conditions

Keywords

Colostomy bagsColostomyBallooningPancakingColostomy bag filter-related complications

Outcome Measures

Primary Outcomes (1)

  • Incidence of ballooning

    Evaluation and comparison of the incidence of ballooning in colostomy bags with active chamber filter system and a protective filter

    21-days

Secondary Outcomes (7)

  • Time of ballooning incidence

    21-days

  • Wear time until ballooning incidence

    21-days

  • Incidence of pancaking

    21-days

  • Time of pancaking incidence

    21-days

  • Wear time until pancaking incidence

    21-days

  • +2 more secondary outcomes

Study Arms (3)

Confidence Be 1-Piece Closed Bag

ACTIVE COMPARATOR

The reference device is CE Marked and already commercially available

Device: Confidence Be 1-Piece Closed Bag

Confidence Natural 1-Piece Closed Bag

ACTIVE COMPARATOR

The reference device is CE Marked and already commercially available

Device: Confidence Natural 1-Piece Closed Bag

Confidence Be go 1-Piece Closed Bag

ACTIVE COMPARATOR

The reference device is CE Marked and already commercially available in Australia

Device: Confidence Be go 1-Piece Closed Bag

Interventions

Active Chamber Filter - Circle Shape

Confidence Be 1-Piece Closed Bag

Protective Filter - Circle Shape

Confidence Natural 1-Piece Closed Bag

Active Chamber Filter - Hexagon Shape

Confidence Be go 1-Piece Closed Bag

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult aged over 18 years
  • Colostomy for 6 months or longer
  • Experiences any filter-related complications, such as ballooning, pancaking, odour, or faecal leakage through the filter, at least once a week (7 days)
  • Independent in colostomy care
  • Using a flat, closed colostomy bag
  • Stoma size (diameter) less than 55 mm
  • Using a colostomy bag with a hydrocolloid wafer (baseplate)
  • Able to read and complete the study questionnaire in English

You may not qualify if:

  • Uses colostomy irrigation
  • Bleeding or broken peristomal skin
  • Receiving or had radiotherapy or chemotherapy in the last 2 months
  • Pregnant or breastfeeding
  • Taking part in another clinical study
  • Currently receiving treatment under the care of a stoma clinical nurse specialist

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central Skin Sciences Institute (CSSI) Salts Healthcare

Birmingham, England, B7 4AA, United Kingdom

RECRUITING

Study Officials

  • Mireille Hamson

    Salt Healthcare

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Clinical Research Coordinator

CONTACT

Clinical Research Nurse

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2024

First Posted

December 18, 2024

Study Start

November 29, 2024

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

December 18, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations